1 Gärtner R. Schilddrüsenerkrankungen, Grundlagen-Diagnostik-Therapie. Wissenschaftliche Verlagsgesellschaft mbH. Stuttgart; 2004.
2 Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, et al. Harrison’s Principles of Internal Medicine. 19th Edition. McGraw-Hill Education; 2015.
3 Monaco F, editor. Thyroid Diseases. CRC Press. Taylor&Francis Group; 2012.
4 Nyström E, Berg GEB, Jansson SKG, Tørring O, Valdemarsson SV. Thyroid Disease in Adults. Springer-Verlag; 2011.
5 Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 13th Edition. Elsevier; 2016.
6 Lutz H. Ultraschallfibel Innere Medizin. 3. Auflage. Springer-Verlag; 2007.
7 World Health Organization, United Nations Children’s Fund, International Council for the Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers, 3rd Edition. Geneva: World Health Organization; 2007.
8 Hess SY, Zimmermann MB. Thyroid volumes in a national sample of iodine-sufficient swiss school children: comparison with the World Health Organization/International Council for the control of iodine deficiency disorders normative thyroid volume criteria. Eur J Endocrinol. 2000;142(6):599–603.
9 Zimmermann MB, Hess SY, Molinari L, De Benoist B, Delange F, Braverman LE, et al. New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. Am J Clin Nutr. 2004;79(2):231–7.
10 Blum M. Technical aspects of thyroid ultrasound. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
11 Lyshchik A, Drozd V, Reiners C. Accuracy of three-dimensional ultrasound for thyroid volume measurement in children and adolescents. Thyroid. 2004;14(2):113–20.
12 Maravall FJ, Gómez-Arnáiz N, Gumá A, Abós R, Soler J, Gómez JM. Reference values of thyroid volume in a healthy, non-iodine-deficient Spanish population. Horm Metab Res. 2004;36(9):645–9.
13 Berghout A, Wiersinga WM, Smits NJ, Touber JL. Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol (Oxf). 1987;26(3):273–80.
14 Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96 278 unselected employees. Thyroid. 2004;14(11):926–32.
15 Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, et al. The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey. J Clin Endocrinol Metab. 1999;84(2):561–6.
16 Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69(3):537–40.
17 Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481–93.
18 Katlic MR, Wang CA, Grillo HC. Substernal goiter. Ann Thorac Surg. 1985;39(4):391–9.
19 Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553–9.
20 Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226–31.
21 Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1991;181(3):683–7.
22 Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154(16):1838–40.
23 Fiche d’information concernant l’iode. Office fédéral de la santé publique; Octobre 2013.
24 Federal Commission for Nutrition. Iodine supply in Switzerland: Current Status and Recommendations. Expert report of the FCN. Zurich: Federal Office of Public Health; 2013.
25 Haldimann M, Bochud M, Burnier M, Paccaud F, Dudler V. Prevalence of iodine inadequacy in Switzerland assessed by the estimated average requirement cut-point method in relation to the impact of iodized salt. Public Health Nutr. 2015;18(8):1333–42.
26 Mesures destinées à garantir un apport d’iode suffisant en Suisse, Office fédéral de la santé publique; Oct 2013.
27 Gizak M. Global Scorecard 2016: moving toward optimal global iodine status. IDD Newsletter; Nov 2016.
28 Zimmermann MB. Iodine Deficiency. Endocr Rev. 2009;30(4):376–408.
29 Hetzel BS. Iodine deficiency disorders (IDD) and their eradication. Lancet. 1983;2(8359):1126–9.
30 Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet. 2008;372(9645):1251–62.
31 Sunde RA. Selenium. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern Nutrition in Health and Disease. 11th Edition. Philadelphia (PA): Lippincott Williams & Wilkins; 2012:225–37.
32 Sunde RA. Selenium. In: Bowman B, Russell R, eds. Present Knowledge in Nutrition. 9th Edition. Washington (DC): International Life Sciences Institute; 2006:480–97.
33 Subcommittee on the Tenth Edition of the RDAs. Selenium. In: Recommended dietary allowances. 10th Edition. National Academy Press. Washington (DC); 1989.
34 U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 25; 2012.
35 Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press. Washington (DC); 2000.
36 Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr. 2008;100(2):254–68.
37 Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256–68.
38 Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, et al. Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter. Endocr Rev. 2005;26(4):504–24.
39 Roger PP, Baptist M, Dumont JE. A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J Cell Biol. 1992;117(2):383–93.
40 Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, et al. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab. 1994;79(1):134–9.
41 Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, et al. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab. 2000;85(6):2270–4.
42 Vitti P. Iodine deficiency disorders. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
43 Ross DS. Clinical presentation and evaluation of goiter in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
44 Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 1948;174(2):555–64.
45 Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. 2001 May;11(5):501–10.
46 Bizhanova A, Kopp P. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology. 2009;150(3):1084–90.
47 Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999;140(8):3404–10.
48 Davies TF. Pathogenesis of Hashimoto’s thyroiditis (chronic autoimmune thyroiditis). In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
49 Davies TF. Pathogenesis of Graves’ disease. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
50 Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev. 1995;16(6):686–715.
51 Ermans AM, Delange F, Van der Velden M, Kinthaert J. Possible role of cyanide and thiocyanate in the etiology of endemic cretinism. Adv Exp Med Biol. 1972; 30:455–86.
52 Gaitan E. Environmental goitrogenesis. Boca Raton (FL): CRC Press; 1989.
53 Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature. 1996;379(6564):458–60.
54 Eskandari S, Loo DDF, Dai G, Levy O, Wright EM, Carrasco N. Thyroid Na+/I− Symporter Mechanism, stoichiometry, and specificity. J Biol Chem. 1997;272(43):27230–8.
55 Bertelsen JB, Hegedus L. Cigarette smoking and the thyroid. Thyroid. 1994 Fall;4(3):327–31.
56 Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, et al. Smoking as a risk factor for Graves’ disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid. 2002;12(1):69–75.
57 Knudsen N, Laurberg P, Perrild H, Pedersen IB, Ovesen L, Jørgensen T. Risk factors for goiter and thyroid nodules. Thyroid. 2002;12(10):879–88.
58 Bundesinstitut für Risikobewertung (2004). Nutzen und Risiken der Jodprophylaxe in Deutschland. Aktualisierte Stellungnahme des Bundesinstituts für Risikobewertung vom 1. Juni 2004.
59 Leung AM, Pearce EN and Braverman LE. Perchlorate, iodine and the thyroid. Best Pract Res Clin Endocrinol Metab. 2010;24(1):133–41.
60 Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect. 2006;114(12):1865–71.
61 LaFranchi S. Congenital and acquired goiter in children. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
62 Roseman BJ and Clark OH. ACS Surgery: Principles and Practice. BC Decker Inc. 2008;3:1–13
63 Berry MF. Approach to the adult patient with a mediastinal mass. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
64 Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA Guidelines: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215–28.
65 Ross DS. Treatment of primary hypothyroidism in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on April 22, 2017).
66 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343–421.
67 Bahn RS, Castro MR. Approach to the patient with nontoxic multinodular goiter. J Clin Endocrinol Metab. 2011;96(5):1202–12.
68 Skeaff SA. Iodine deficiency in pregnancy: the effect on neurodevelopment in the child. Nutrients. 2011;3(2):265–73.